Peak health "Baibo into the enterprise" assessment ended
Release time:
2020-08-14
Peak Health "Baibo Entering Enterprise" Assessment Completed
News 10# August 25 On the afternoon of the 10th, Jiang Dejin, Deputy Minister of Organization Department and Director of Recruitment Bureau of Wucheng District Party Committee, Zhang Xiongwei, Deputy Director of Talent Office of District Party Committee Organization Department, Wang Xusheng, Deputy Director of Science and Technology Bureau, Zhang Yi, Chief of Industry Section, at Jianfeng Health Technology Company, the third batch of "Baibo Enterprise" assessment in 2018 was conducted. Dr. Pu Shoucheng of Zhejiang Normal University and Chen Daiyou, general manager of Jianfeng Health, and other relevant personnel participated in the assessment meeting.
Jianfeng Health signed a contract with Dr. Pu Shoucheng of Zhejiang Normal University in , 2016 , , . Dr. Pu entered Jianfeng Health Technology and was mainly responsible for the research and development of innovative Chinese herbal pieces and the exploration of plant extraction technology in the research and development center, and assisted in the research and development project and application of health food. At the meeting, Dr. Pu first summarized the work of 2 years in-depth peak health. He mainly carried out the experimental design of "Research on Purification Process of Hypoglycemic Active Component D Pinol in Cornbean Extract"; Establishment of detection method for D Pinol content in carob extract; 2 organized company personnel to visit the school for exchange and docking, use the public platform of the school to complete other projects for the company; Organize the staff of the research and development department and the quality department to conduct "research on the development of functional health products" and "application analysis of LCMS " learning lectures 2 times; through the freeze dryer and mass spectrometry laboratory of the school's most important platform, the "experiment of freeze-drying gastroma tablets" and "LCMS identification and analysis experiment of Ophiopogonis acid in Pinellia ternata" 2 times were completed. And promote the inclusion of peak health into the list of shared enterprises in the virtual simulation laboratory of biotechnology in Zhejiang Normal University; during the period, the patent specification "method for purifying D- pinitol from carob aqueous extract" was also drafted.
Chen Daiyou, on behalf of Jianfeng Health, evaluated and fully affirmed Dr. Pu 2 years of work. Yang Hao, manager of the research and development department, also summarized Dr. Pu's work in the technical field. Jiang Dejin and his party inquired about the details of the project, introduced the talent policy of the municipal government, and put forward relevant opinions and suggestions.
Chen Daiyou said that the introduction of doctoral talents has solved the demand of enterprises for high-quality talents, further enriched the scientific research team and improved the research and development capability of enterprises. Peak Health has submitted the recommendation form for doctoral candidates to enter enterprises in 2018 and the solicitation form for enterprises to introduce doctoral candidates in 2019 , in the future, doctoral talents in analysis, detection and biotechnology will be introduced to help Jianfeng Health improve relevant detection methods and improve the development and utilization of functional ingredients of traditional Chinese medicine and plant extracts. (Xu Feng)
News Link:
"Hundred Doctors Entering Enterprises Plan" is referred to as "Baibo Entering Enterprises". It is the leading group of talents work of Jinhua Municipal Committee of the Communist Party of China to implement the innovation-driven development strategy of Jinhua Municipal Committee, further promote the cooperation of industry-university-research alliance, and promote the sharing of human resources and scientific research results between universities and institutions and local enterprises, serve the local economic and social development, promote the government, enterprises, universities, talents win-win and start the implementation. It is planned to spend years to arrange 20 doctors and professors from colleges and universities (mainly in Zhejiang undergraduate colleges and universities) to take up temporary posts in Jinhua high-tech enterprises as research and development leaders, with a term of office of . The positions are generally assistant to the president (director) of the enterprise research institute (research and development center, technology center). Through doctors and professors to carry out scientific research activities on the front line of enterprises, we can speed up the production and transformation of scientific research achievements of colleges and universities in Jinhua City, promote the tackling of technical problems of enterprises, and promote the establishment of closer cooperation between universities and enterprises and the sharing mechanism of scientific and technological achievements. The relevant municipal departments will organize the annual assessment of the scientific research activities and achievements of the temporary staff every year, and the municipal finance will bear the reward funds for the temporary staff, while the enterprises that receive the temporary staff will be given priority to the support of technical transformation, science and technology, talents and other projects.
More information
2020
11-03
Jinhua Municipal Party Committee Secretary Chen Long: I wish your enterprise better and better
On the morning of October 16, Chen long, secretary of the Jinhua Municipal CPC Committee, and his entourage came to the construction site of Jianfeng Pharmaceutical's internationalization project to investigate and affirmed the good development status and clear future development ideas of Jianfeng Pharmaceutical. At the construction site, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, introduced the overall situation of the investment scale, factory layout, and production direction of the Jianfeng Pharmaceutical internationalization project to Chen Long and his entourage. Huang Jinlong, general manager of the pharmaceutical company, accompanied Chen Long and his entourage to visit the preparation workshop under construction. The construction site is neat, tidy and orderly, and the facilities and equipment are perfect and advanced, all have been unanimously affirmed by the leaders who came to investigate. When learning that the peak internationalization project has introduced international advanced equipment, built in accordance with European and American standards, and its products are oriented to the international market, Chen long said happily: "your goals are very clear and your thinking is very clear. I wish your enterprise better and better!" (this newspaper reporter)
2020
10-23
Liu Haiping, vice mayor of Pu'er City, said during the survey: "Peak is an enterprise with feelings"
On September 30, Liu Haiping, member of the standing Committee of the Pu'er Municipal CPC Committee and vice mayor of Pu'er City, Yunnan Province, and relevant responsible persons of Pu'er City and Simao District, visited the company for investigation and research, and communicated with the leaders of the group company on topics such as further strengthening cooperation between the two sides. "Yunnan Jianfeng has not only developed well in Pu'er these years, achieved good benefits and contributed considerable tax revenue, but also made great contributions to promoting the economic development of Pu'er and the stability of the southwest border region. It is our 'star enterprise' and 'baby enterprise '." Liu Haiping said so in the exchange. He said that Pu'er is an important window for the implementation of the "Belt and Road" concept. It has good conditions in natural resources, transportation, electricity, etc., and the peak is a "sentimental enterprise" and has a good foundation in the local area. Strengthen cooperation; various government departments will also earnestly "stand on the platform" and "do a good job as a shopkeeper" to serve enterprises. Chairman Jiang Xiaomeng and General Manager Yu Jianhong exchanged views with Liu Haiping and his party on the layout of peak industry and strengthening cooperation with Pu 'er. After that, accompanied by General Manager Yu Jianhong and Deputy General Manager Huang Jinlong, Liu Haiping and his party visited the Jinxi Factory of Jianfeng Pharmaceutical Factory. (this newspaper reporter)
2020
10-09
The first batch of Jianfeng Pharmaceuticals to enter Jinhua (Shanghai) Science and Technology Center
News from our newspaper On September 16, at the unveiling ceremony of the Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Innovation Center and Jinhua (Shanghai) Talent Building, Jiang Xiaomeng, chairman of the group company and chairman of the pharmaceutical company, took over from Chen Long, secretary of the Jinhua Municipal Party Committee. The golden key with big red flowers. Spike Pharmaceuticals became one of the first seven companies to enter the center. The Yangtze River Delta G60 Jinhua (Shanghai) Science and Technology Center and Jinhua (Shanghai) Talent Building are the first "Science and Technology and Talent Enclave" in Shanghai in the nine cities of the Yangtze River Delta G60 Science and Technology Corridor, and the first cross-regional industrial collaborative innovation center in the Science and Technology Corridor. The center is located in Shanghai Lingang Songjiang Science and Technology City, with a total area of nearly 10,000 square meters. It includes two parts: science and technology innovation and talent service. There are five major centers, including talent service center, science and technology innovation exhibition center, business incubation center, enterprise research and development center, and talent project roadshow center. It is a science and technology innovation platform that integrates the functions of project incubation, recruitment of institutions, and talent recruitment. Chen Long, secretary of the Jinhua Municipal Party Committee, said in his speech at the unveiling ceremony that in the future, all scientific and technological enterprises stationed in Jinhua (Shanghai) Science and Technology Center and Talent Building can equally enjoy Jinhua's local science and technology and talent policies, so as to further break the space limitation, enable talents from the two places to share the most favorable treatment and convenient services, help enterprises to develop in Shanghai and achieve industrialization in Jinhua. At the ceremony, leaders such as Chen Long, secretary of the Jinhua Municipal Party Committee, and Cheng Xiangmin, secretary of the Shanghai Songjiang District Party Committee, awarded seven companies, including Jianfeng Pharmaceutical, the golden key to symbolize their entry. At the Yangtze River Delta Integrated Talent Cooperation Project Symposium held after the ceremony, Jiang Xiaomeng spoke as a representative of Jinhua entrepreneurs. He believed that Shanghai, as an international metropolis, has an agglomeration effect on high-end intellectual resources and grasps the first-class element resources of scientific and technological innovation in China and even the world. The establishment of G60 Jinhua (Shanghai) science and technology innovation center and talent building in the Yangtze River Delta helps Jinhua enterprises to take off in scientific and technological innovation and information exchange, which will provide strong and continuous scientific and technological support and intellectual support for the long-term development of enterprises in the future, and attract more excellent domestic and foreign talents to serve Jinhua enterprises, It plays a key role in further improving scientific research ability, innovation ability and personnel training. During the event, Jiang Xiaomeng successively accepted on-site interviews with "People's Daily", "Liberation Daily", "Zhejiang Daily" and other media. He said that the establishment of science and technology innovation and talent bases in Shanghai has greatly enhanced Jinhua's attractiveness to enterprises. "With this base, we don't need to introduce talents to Jinhua, but directly recruit talents in Shanghai, and at the same time enjoy Jinhua's various talent recruitment policies, and change Shanghai talents to Jinhua's use. This is a kind of bold. The innovation has greatly solved the dilemma of attracting talents for enterprises." As a settled enterprise, it will also make full use of its own advantages to continuously inject resource vitality into the science and technology innovation center, and continue to contribute to the long-term development of Jinhua's economy. (this newspaper reporter)
2020
09-22
Spike Pharmaceutical Added New Products
On September 3, Spike Pharmaceutical Company received the approval of the State Drug Administration for the registration of esomeprazole sodium for injection (approval number: 2020S00572). Esomeprazole sodium for injection is mainly used to treat low-risk patients with gastroesophageal reflux disease and acute gastric or duodenal ulcer bleeding when oral therapy is not applicable. It has been listed in the National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug List (2017 Edition) ", classified as Class B. According to industry statistics, 30 companies including Zhengda Tianqing and Qilu Pharmaceutical have been approved for listing in China. In 2019, domestic sales (including urban and county-level public hospitals, community and township health centers) were about 3.317 billion yuan. Jianfeng Pharmaceutical submitted an application for registration of esomeprazole sodium for injection to the State Food and Drug Administration in November 2013 and was accepted. Up to now, Jianfeng Pharmaceutical has invested nearly 15 million yuan in research and development for the project and has a corresponding production line. This time to obtain the injection of esomeprazole sodium drug registration approval, marking the peak pharmaceutical has the drug production, sales qualification, will further enrich the peak pharmaceutical product line, help to enhance the competitiveness of the peak pharmaceutical business. (Lu Yating, Liu Yang)
2020
09-11